Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transgelin 2 pseudogene 1 (TAGLN2P1) is a human pseudogene; it is a non-protein-coding genetic element related to the transgelin-2 (TAGLN2) gene. TAGLN2P1 does not encode a functional protein and is not implicated in biological pathways, disease mechanisms, or drug interactions. It should not be confused with the functional gene *transgelin-2* (TAGLN2), which is involved in actin cytoskeleton regulation and has roles in immunity and cancer[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transgelin 2 pseudogene 1 (TAGLN2P1).